Could magnetic pulses lift depression in schizophrenia?

NCT ID NCT05671185

Recruiting now Symptom relief Sponsor: National Taiwan University Hospital Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests whether repetitive transcranial magnetic stimulation (rTMS) can reduce depression in people with schizophrenia. About 180 adults will receive rTMS to the left prefrontal cortex. Researchers will measure changes in mood, thinking, and other symptoms over time.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: repetitive transcranial magnetic stimulation (rTMS)
What this could lead to: If it works, this could offer a non-drug option to treat depression in people with schizophrenia, potentially reducing suicide risk and improving quality of life.
What could go wrong: This is an early-stage study with no phase, so results are uncertain. The effect may be small, and not all participants may benefit. rTMS is generally safe but can cause headache or scalp discomfort.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for SCHIZOAFFECTIVE DISORDER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

schizoaffective disorder schizophrenia

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

SCHIZOPHRENIA AND RELATED DISORDERS

Contacts and locations

Locations

Department of Psychiatry, National Taiwan University Hospital Yunlin Branch
RECRUITING

Douliu, Yunlin, 640, Taiwan

More trials for these conditions

Other studies related to the condition(s) this trial covers.